Home > Journals > Otorinolaringologia > Past Issues > Otorinolaringologia 2000 June;50(2) > Otorinolaringologia 2000 June;50(2):125-31

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

THERAPEUTICAL NOTES   

Otorinolaringologia 2000 June;50(2):125-31

Copyright © 2009 EDIZIONI MINERVA MEDICA

language: Italian

Mucoregulators in otorinolaryngology phlogosis

Ralli G. *, Celestino D. **

*Università degli Studi di Roma «La Sapienza» - Roma II Clinica Otorinolaringoiatrica (Direttore: Prof. M. De Vincentiis) **Presidente dell’Associazione Italiana Otorinolaringoiatrica dei Liberi Professionisti (AIOLP)


PDF


Upper air way and digestive tract anatomy and physiology (VADS) are shortly discussed referring to the physiopathological mechanisms that govern the inflammatory processes of those mucous membranes. A particular emphasis is stressed on the negatives effects of the atmospheric pollution on the evolution of VADS phlogosis. Subsequently, the drugs active on mucous membrane secretions are passed in review and is made evident the SCMC-Lys for its ability to balance the relationship between sialomucins and fucomucins and for its anti-oxidant and scavenger activity. The generic SCMC-Lys indication for VADS mucousities treatment appears even more appropriated for the tympanic cavum phlogosis. In fact, the demonstrated possibility to modulate this district’s ionic transport, just modifying the concentration of free radicals, leaves to catch a glimpse of the concrete possibility to positively influence the medium secretion otitis (OMS) evolution.

top of page